| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/14728222.10.4.489 |
| P698 | PubMed publication ID | 16848686 |
| P2093 | author name string | Thomas M Zollner | |
| Yi-Yang Yvonne Li | |||
| H Daniel Perez | |||
| P2860 | cites work | Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy | Q24683776 |
| JAM2 interacts with alpha4beta1. Facilitation by JAM3 | Q28205206 | ||
| Progressive multifocal leukoencephalopathy in a patient treated with natalizumab | Q28255536 | ||
| Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis | Q28255548 | ||
| Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease | Q28255557 | ||
| The human polyomavirus, JCV, uses serotonin receptors to infect cells | Q28294207 | ||
| VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responses | Q28572455 | ||
| A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis | Q29616119 | ||
| Progressive multifocal leukoencephalopathy in transplant recipients | Q30979159 | ||
| Rodent models of lymphocyte migration. | Q33636023 | ||
| JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. | Q33838943 | ||
| The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen | Q33859887 | ||
| Mechanisms of stem-/progenitor-cell mobilization: the anti-VLA-4 paradigm | Q33863470 | ||
| Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow | Q33926770 | ||
| Cell-type specific protein binding to the enhancer of simian virus 40 in nuclear extracts | Q34162554 | ||
| A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. | Q34328813 | ||
| Transplanted bone marrow generates new neurons in human brains | Q34330924 | ||
| Adult stem cells for tissue repair - a new therapeutic concept? | Q35194623 | ||
| A predominant role of integrin alpha 4 in the spontaneous development of autoimmune diabetes in nonobese diabetic mice | Q35994146 | ||
| Anti-adhesion therapies | Q36162908 | ||
| Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin | Q36221398 | ||
| Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis | Q36229960 | ||
| The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules | Q36231136 | ||
| Therapeutic anti-integrin (alpha4 and alphaL) monoclonal antibodies: two-edged swords? | Q36291069 | ||
| VLA-4 mediates CD3-dependent CD4+ T cell activation via the CS1 alternatively spliced domain of fibronectin | Q36353651 | ||
| Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma | Q36361169 | ||
| A VCAM-like adhesion molecule on murine bone marrow stromal cells mediates binding of lymphocyte precursors in culture | Q36530133 | ||
| Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin | Q36589367 | ||
| Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and very late antigen 4 adhesion receptors | Q36657860 | ||
| Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals. | Q37492573 | ||
| Interaction of the human polyomavirus, JCV, with human B-lymphocytes | Q38325743 | ||
| Liver from bone marrow in humans. | Q38464633 | ||
| HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver | Q39785808 | ||
| Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. | Q41541656 | ||
| VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. | Q41743693 | ||
| Monocyte migration to arthritis in the rat utilizes both CD11/CD18 and very late activation antigen 4 integrin mechanisms | Q42026278 | ||
| An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex) in patients with multiple sclerosis | Q42637668 | ||
| Lack of beta 1 integrin gene in embryonic stem cells affects morphology, adhesion, and migration but not integration into the inner cell mass of blastocysts | Q42771254 | ||
| Rat blood neutrophils express very late antigen 4 and it mediates migration to arthritic joint and dermal inflammation | Q42943475 | ||
| Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions | Q44099207 | ||
| Allergen-induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation | Q44518704 | ||
| Natalizumab plus interferon beta-1a for relapsing multiple sclerosis | Q44825022 | ||
| Increased number of CD34+ cells in nasal mucosa of allergic rhinitis patients: inhibition by a local corticosteroid | Q45222906 | ||
| Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. | Q46007698 | ||
| Integrin-mediated long-term B cell retention in the splenic marginal zone. | Q46500117 | ||
| A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis | Q46945984 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 489-499 | |
| P577 | publication date | 2006-08-01 | |
| P1433 | published in | Expert Opinion on Therapeutic Targets | Q5421214 |
| P1476 | title | Fatalities in natalizumab treatment--a 'no go' for leukocyte recirculation approaches? | |
| P478 | volume | 10 |
| Q88601420 | A Programme for Risk Assessment and Minimisation of Progressive Multifocal Leukoencephalopathy Developed for Vedolizumab Clinical Trials |
| Q24646861 | Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block |
| Q36832873 | Immunopathogenesis of multiple sclerosis |
| Q44019565 | Infratentorial progressive multifocal leukoencephalopathy in a patient treated with fludarabine and rituximab |
| Q37349724 | Manipulation of acute inflammatory lung disease. |
| Q37814815 | Monoclonal antibody therapy in multiple sclerosis: Paradigm shifts and emerging challenges |
| Q37606003 | Polyomaviruses of nonhuman primates: implications for research. |
Search more.